By Conor Coyle
Date: Tuesday 06 Sep 2016
(ShareCast News) - US manufacturing company Danaher Corp. is set to buy molecular diagnostics firm Cepheid in a deal worth around $4bn including debt.
No recent information was found.
Currency | US Dollars |
Share Price | $ 203.90 |
Change Today | $ -7.50 |
% Change | -3.55 % |
52 Week High | $278.02 |
52 Week Low | $174.64 |
Volume | 3,172,408 |
Shares Issued | 719.10m |
Market Cap | $146,624m |
Beta | 0.95 |
RiskGrade | 135 |
Strong Buy | 12 |
Buy | 8 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 23 |
Time | Volume / Share Price |
16:00 | 483,837 @ $203.90 |
15:59 | 216 @ $203.95 |
15:59 | 300 @ $203.95 |
15:59 | 100 @ $203.95 |
15:59 | 520 @ $203.95 |
You are here: research